Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Stomatitis 4Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Pancreatic Neoplasms 1Oral Ulcer 1Esophagitis 1Carcinoma, Squamous Cell 1

Interventions

Fibroblast Growth Factor 7 9avasopasem manganese 4Cisplatin 4Radiotherapy, Intensity-Modulated 3Injections 3golotimod 2Saline Solution 2Radiotherapy 2RRx-001 2Mouthwashes 2Low-Level Light Therapy 2FGF20 protein, human 2Drug Therapy 2Benzydamine 2meclocycline 1hydrated silica gel-based toothpaste 1dusquetide 1cobiprostone 1clazakizumab 1brilacidin 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Whole-Body Irradiation 1Water 1Transplantation Conditioning 1Standard of Care 1Radiation 1Prednisolone 1Niacinamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Stomatitis × avasopasem manganese × Clear all
NCT03689712 2023-10-24

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

Galera Therapeutics, Inc.

Phase 3 Completed
455 enrolled 11 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis, Oral Ulcer

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
38 enrolled 10 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
223 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT01921426 2016-09-22

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Galera Therapeutics, Inc.

Phase 1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡